Browse our B-Cell CLL/lymphoma 9-Like Proteins (BCL9L)

Full name:
B-Cell CLL/lymphoma 9-Like Proteins (BCL9L)
On are 3 B-Cell CLL/lymphoma 9-Like (BCL9L) Proteins from 2 different suppliers available. Additionally we are shipping B-Cell CLL/lymphoma 9-Like Antibodies (33) and B-Cell CLL/lymphoma 9-Like Kits (2) and many more products for this protein. A total of 48 B-Cell CLL/lymphoma 9-Like products are currently listed.
2610202E01Rik, 8030475K17Rik, A330041G23Rik, B9L, BC003321, bcl9-2, BCL9L, DLNB11, Gm130, LGS
list all proteins Gene Name GeneID UniProt
BCL9L 77578 Q9D219
BCL9L 607 O00512
Rat BCL9L BCL9L 300673  

Show all synonyms

B-Cell CLL/lymphoma 9-Like Proteins (BCL9L) by Origin

Select your origin of interest

More Proteins for B-Cell CLL/lymphoma 9-Like Interaction Partners

Mouse (Murine) B-Cell CLL/lymphoma 9-Like (BCL9L) interaction partners

  1. ARX positively regulates Wnt (show WNT2 Proteins)/ beta-catenin (show CTNNB1 Proteins) signaling and the C-terminal domain of ARX interacts with the armadillo (show PKP1 Proteins) repeats in beta-catenin (show CTNNB1 Proteins) to promote Wnt (show WNT2 Proteins)/beta-catenin (show CTNNB1 Proteins) signaling. In addition, we found BCL9 (show BCL9 Proteins) and P300 (show NOTCH1 Proteins) also interact with ARX to modulate Wnt (show WNT2 Proteins)/beta-catenin (show CTNNB1 Proteins) signaling.

  2. Study demonstrates that the Golgi resident protein GM130 (show GOLGA2 Proteins) activates the spindle assembly factor TPX2 (show DAZL Proteins) to nucleate microtubules around the Golgi and further captures them to couple mitotic membranes to the spindle.

  3. BCL9-2 induces ER positive breast cancers in vivo, regulates ER expression by a novel ss-catenin independent mechanism in breast cancer cells.

  4. Pax6 (show PAX6 Proteins), the master regulator of eye development, directly activates Bcl9 (show BCL9 Proteins)/9l transcription.

  5. Data show that the GCM1/syn (show CTNNB1 Proteins)cytin (show BCL9 Proteins)-B pathway is significantly downregulated in the placenta of BCL9L-defici (show GCM1 Proteins)ent mice (show ERVW-1 Proteins)and that the fusion and differentiation of ST-II cells are blocked.

  6. BCL9-2 promotes early phases of intestinal tumor progression in humans and in transgenic mice. BCL9-2 increases the expression of a subset of canonical Wnt (show WNT2 Proteins) target genes but also regulates genes that are required for early stages of tumor progression.

  7. These results suggest a critical role of BCL9 (show BCL9 Proteins)/9-2 in the Wnt (show WNT2 Proteins)-mediated regulation of adult, as opposed to embryonic, myogenic progenitors.

  8. We demonstrated that nuclear B9L expression was closely associated with the high nuclear grade cancer phenotype and the expression of ErbB2/HER-2 (show ERBB2 Proteins) in breast cancers.

Human B-Cell CLL/lymphoma 9-Like (BCL9L) interaction partners

  1. MEF2D (show MEF2D Proteins)-BCL9 (show BCL9 Proteins)-positive patients had B-cell precursor immunophenotype and were characterized as being older in age, being resistant to chemotherapy, having very early relapse, and having leukemic blasts that mimic morphologically mature B-cell leukemia with markedly high expression of HDAC9 (show HDAC9 Proteins).

  2. BCL9L dysfunction contributes to aneuploidy tolerance in both TP53 (show TP53 Proteins)-WT and mutant cells by reducing basal caspase-2 (show CASP2 Proteins) levels and preventing cleavage of MDM2 (show MDM2 Proteins) and BID (show BID Proteins).

  3. it was demonstrated that miR218 modulated a novel molecular target and the present study provided novel insights into potential mechanisms of RCC (show XRCC1 Proteins) oncogenesis.

  4. findings indicate that BCL9 (show BCL9 Proteins) most likely does not harbor a common genetic variant that can increase the risk for schizophrenia in the Japanese population

  5. BCL9 (show BCL9 Proteins)/9L-beta-catenin (show CTNNB1 Proteins) Signaling is Associated With Poor Outcome in Colorectal Cancer

  6. BCL9 (show BCL9 Proteins) is a molecular driver of DCIS invasive progression.

  7. PCDH10 (show PCDH10 Proteins) antagonized MM cell proliferation via the downregulation of Wnt (show WNT2 Proteins)/beta-catenin (show CTNNB1 Proteins)/BCL-9 (show BCL9 Proteins) signaling, whereas PCDH10 (show PCDH10 Proteins) repressed the expression of AKT (show AKT1 Proteins) to promote the expression of GSK3beta and then to restrain the activation of beta-catenin (show CTNNB1 Proteins)

  8. The inhibition of the transcriptional activity of BCL9-2 by WWOX (show WWOX Proteins) and HDAC3 (show HDAC3 Proteins) constitutes a new molecular mechanism and provides new insight for a broad range of cancers.

  9. BCL9-2 induces ER positive breast cancers in vivo, regulates ER expression by a novel ss-catenin independent mechanism in breast cancer cells.

  10. By beta-catenin's association with LEF1 (show LEF1 Proteins) and BCL9-2/B9L.

B-Cell CLL/lymphoma 9-Like (BCL9L) Protein Profile

Protein Summary

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Alternative names and synonyms associated with B-Cell CLL/lymphoma 9-Like (BCL9L)

  • B-cell CLL/lymphoma 9-like (BCL9L)
  • B cell CLL/lymphoma 9 (Bcl9)
  • B cell CLL/lymphoma 9-like (Bcl9l)
  • B-cell CLL/lymphoma 9 (BCL9)
  • B-cell CLL/lymphoma 9-like (Bcl9l)
  • B-cell CLL/lymphoma 9-like (bcl9l)
  • 2610202E01Rik protein
  • 8030475K17Rik protein
  • A330041G23Rik protein
  • B9L protein
  • BC003321 protein
  • bcl9-2 protein
  • BCL9L protein
  • DLNB11 protein
  • Gm130 protein
  • LGS protein

Protein level used designations for BCL9L

B-cell CLL/lymphoma 9-like , b-cell CLL/lymphoma 9-like protein-like , B-cell CLL/lymphoma 9 protein , B-cell lymphoma 9 protein , bcl-9 , nuclear co-factor of beta-catenin signalling , B-cell CLL/lymphoma 9-like protein , B-cell lymphoma 9-like protein , BCL9-like protein , BCL9-related beta-catenin-binding protein , protein BCL9-2 , protein legless homolog

419785 Gallus gallus
451596 Pan troglodytes
489377 Canis lupus familiaris
539340 Bos taurus
100063146 Equus caballus
100444640 Pongo abelii
100515846 Sus scrofa
77578 Mus musculus
80288 Mus musculus
607 Homo sapiens
100155378 Sus scrofa
283149 Homo sapiens
300673 Rattus norvegicus
449532 Danio rerio
Selected quality suppliers for B-Cell CLL/lymphoma 9-Like Proteins (BCL9L)
Did you look for something else?